Wynne H A, Cope L H, James O F, Rawlins M D, Woodhouse K W
Wolfson Unit of Clinical Pharmacology, Newcastle upon Tyne.
Age Ageing. 1989 Nov;18(6):415-8. doi: 10.1093/ageing/18.6.415.
Six healthy young subjects (aged 23-32 years), six healthy elderly subjects (over 60 years) and six hospitalized long-stay geriatric subjects over 60 years received single oral doses of acetanilide. Acetanilide clearance was similar in the fit and frail elderly subjects at 26.4 +/- 2.5 and 26.3 +/- 3.6 l/h and significantly lower (p less than 0.05) than in the young subjects at 39.0 +/- 1.9 l/h. Liver volumes, measured by ultrasound, were significantly less in the elderly than in the young subjects, whether expressed in absolute terms or per unit body weight (p less than 0.05). When acetanilide clearance was expressed per unit volume of liver, no change occurred with age or frailty. These results suggest that a reduced liver size may be an important contributor to the reduced elimination of capacity limited drugs in elderly man.
六名健康年轻受试者(年龄23 - 32岁)、六名健康老年受试者(60岁以上)和六名60岁以上住院长期护理老年受试者接受了单次口服乙酰苯胺剂量。健康老年受试者和体弱老年受试者的乙酰苯胺清除率相似,分别为26.4±2.5和26.3±3.6升/小时,显著低于年轻受试者的39.0±1.9升/小时(p<0.05)。通过超声测量的肝脏体积,无论以绝对值还是单位体重表示,老年受试者均显著小于年轻受试者(p<0.05)。当以单位肝脏体积表示乙酰苯胺清除率时,未随年龄或身体虚弱程度发生变化。这些结果表明,肝脏体积减小可能是老年男性中容量限制型药物消除能力降低的一个重要因素。